Halozyme To Report Fourth Quarter and Full Year 2023 Financial and Operating Results

SAN DIEGO, Feb. 8, 2024 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced it will release its fourth quarter and full year 2023 financial and operating results on Tuesday, February 20, 2024, following the close of trading. Halozyme will host a…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks